US STOCK

ORKA Stock Analysis

US stocks · market data · technical indicators

Oruka Therapeutics, Inc.
ORKAUS stocks
Quote delayed 15 min
10/27 上午01:02 updated
$92.79
+12.64+15.77%
Open
$81.98
High
$93.42
Low
$81.98
Volume
90.74萬
ORKA price history
+7.29%
Open
84.19
Latest
90.33
High
90.33
Low
71.93
Average
80.34
Advertisement
Financial snapshot
Yahoo Finance

ORKA - Oruka Therapeutics, Inc.

EPS
-2.07USD
Forward EPS
-2.86USD
P/E
--
Forward P/E
-31.56x
P/B
4.96x
ROE
-18.23%
ROA
-12.95%
Operating margin
0.00%
Profit margin
0.00%
Revenue growth
--
Earnings growth
--
Dividend yield
0.00%
Financial statements
2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Revenue$0$0$0$0$0—
Operating income-$50.11M-$36.43M-$34.43M-$34.10M-$28.43M—
Net income-$41.21M-$31.82M-$29.58M-$30.28M-$24.57M—
Basic EPS-0.55-0.48—-0.55-0.46-0.40
Diluted EPS-0.55-0.48—-0.55-0.46-0.40
Estimates vs actuals
Next earnings
2026-11-11
EPS estimate
-0.62
Revenue estimate
$0
Last surprise
-9.95%
DateEstimateActualSurprise
2026-11-11-0.62Not reported—
2026-08-10-0.50-0.55-9.95%
2026-05-13-0.54-0.48+10.61%
2026-03-12-0.62-0.45+26.89%
2025-11-12-0.52-0.55-4.96%
2025-08-11-0.43-0.46-6.36%
2025-05-14-0.44-0.40+9.09%
2025-03-06-0.41-0.49-18.55%
2024-11-13-0.32-1.46-351.55%
Institutional holders
InstitutionQuarterValue heldPortfolio weight
STATE STREET CORP2026-06-30$254.4M0.01%
CITADEL ADVISORS LLC2026-06-30$106.5M0.01%
VANGUARD GROUP INC2025-12-31$74.4M0.00%

13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.

Analyst ratings
13 analysts
Mean target
$156.17
Target range
$117.00 – $200.00
Implied upside
72.88%
Strong buy
2
Buy
11
Hold
0
Sell
0
Strong sell
0
Advertisement